The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of carboplatin with or without nivolumab in first- or second-line metastatic TNBC.
 
Ana Christina Garrido-Castro
No Relationships to Disclose
 
William Thomas Barry
Research Funding - Pfizer (Inst)
Other Relationship - ARMO BioSciences
 
Tiffany A. Traina
Consulting or Advisory Role - Advaxis; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech/Roche; Genomic Health; Innocrin Pharma; Medivation; Merck; Pfizer; Puma Biotechnology; Samsung
Speakers' Bureau - Roche/Genentech
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Innocrin Pharma (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst)
 
Robert Wesolowski
Consulting or Advisory Role - Agenus; Novartis; Pfizer (Inst)
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Agenus; Novartis; Pfizer
 
Nadine M. Tung
Honoraria - AstraZeneca
Research Funding - AstraZeneca
 
Tanya Keenan
Employment - 5AM Ventures (I)
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Genome Medical; Syapse; Tango Therapeutics
Consulting or Advisory Role - Genome Medical; InVitae; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis
 
Nancy U. Lin
Research Funding - Cascadian Therapeutics; Genentech
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases
 
Eric P. Winer
Honoraria - Genentech/Roche; Lilly; Tesaro
Consulting or Advisory Role - InfiniteMD; Leap Therapeutics
Research Funding - Genentech (Inst)
 
Ian E. Krop
Employment - AMAG Pharmaceuticals (I)
Leadership - AMAG Pharmaceuticals (I)
Stock and Other Ownership Interests - AMAG Pharmaceuticals (I)
Honoraria - Genentech/Roche
Consulting or Advisory Role - Daiichi Sankyo; Genentech/Roche; Seagen
Research Funding - Genentech
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; Genentech; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Bristol-Myers Squibb; Eisai; Eisai; Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)